Rating History for GlaxoSmithKline (GSK) by UBS

More Stocks Rated by UBS | Latest Ratings for GSK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/11/2022 Michael Leuchten Downgrade Sell
(Neutral)		 N/A
(N/A)		 33.47
(51.96)		 55.24% Details